119 related articles for article (PubMed ID: 11205276)
21. Labdane-type diterpenes: thermal effects on phospholipid bilayers, incorporation into liposomes and biological activity.
Matsingou C; Hatziantoniou S; Georgopoulos A; Dimas K; Terzis A; Demetzos C
Chem Phys Lipids; 2005 Dec; 138(1-2):1-11. PubMed ID: 16182267
[TBL] [Abstract][Full Text] [Related]
22. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
Allen TM; Mumbengegwi DR; Charrois GJ
Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
[TBL] [Abstract][Full Text] [Related]
23. Cationic phospholiposomes: efficient delivery vehicles of anticancer derivatives of ATP to multiple myeloma cells.
Wang L; MacDonald RC
J Liposome Res; 2011 Dec; 21(4):306-14. PubMed ID: 21457078
[TBL] [Abstract][Full Text] [Related]
24. Design and development of liposomes incorporating a bioactive labdane-type diterpene. In vitro growth inhibiting and cytotoxic activity against human cancer cell lines.
Matsingou C; Dimas K; Demetzos C
Biomed Pharmacother; 2006 May; 60(4):191-9. PubMed ID: 16675195
[TBL] [Abstract][Full Text] [Related]
25. [Preliminary study on sea cucumber saponin-nobiliside A liposome and its hemolytic activity].
Xiong Y; Guo D; Zheng XL; Sun P; Xu LY; Chen JM
Yao Xue Xue Bao; 2008 Feb; 43(2):214-20. PubMed ID: 18507352
[TBL] [Abstract][Full Text] [Related]
26. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release.
Lindner LH; Hossann M; Vogeser M; Teichert N; Wachholz K; Eibl H; Hiddemann W; Issels RD
J Control Release; 2008 Jan; 125(2):112-20. PubMed ID: 18022271
[TBL] [Abstract][Full Text] [Related]
27. The antitumor activity of PNA modified vinblastine cationic liposomes on Lewis lung tumor cells: In vitro and in vivo evaluation.
Li XT; He ML; Zhou ZY; Jiang Y; Cheng L
Int J Pharm; 2015 Jun; 487(1-2):223-33. PubMed ID: 25895716
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
Lei XS; Yu XD; Yin L; Liu ZH; Tang PC
Bioorg Med Chem Lett; 2008 Aug; 18(16):4602-5. PubMed ID: 18653334
[TBL] [Abstract][Full Text] [Related]
29. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
[TBL] [Abstract][Full Text] [Related]
30. Encapsulation of lipopeptides within liposomes: effect of number of lipid chains, chain length and method of liposome preparation.
Liang MT; Davies NM; Toth I
Int J Pharm; 2005 Sep; 301(1-2):247-54. PubMed ID: 16054787
[TBL] [Abstract][Full Text] [Related]
31. Liposomal formulations from phospholipids of Greek almond oil. Properties and biological activity.
Malisiova F; Hatziantoniou S; Dimas K; Kletstas D; Demetzos C
Z Naturforsch C J Biosci; 2004; 59(5-6):330-4. PubMed ID: 18998396
[TBL] [Abstract][Full Text] [Related]
32. Free versus liposome-encapsulated lignocaine hydrochloride topical applications.
el-Ridy MS; Khalil RM
Pharmazie; 1999 Sep; 54(9):682-4. PubMed ID: 10522272
[TBL] [Abstract][Full Text] [Related]
33. Drug resistance in prostate cancer cell lines is influenced by androgen dependence and p53 status.
Serafin AM; Akudugu JM; Bohm L
Urol Res; 2002 Oct; 30(5):289-94. PubMed ID: 12389116
[TBL] [Abstract][Full Text] [Related]
34. Studies on tamoxifen encapsulated in lipid vesicles: effect on the growth of human breast cancer MCF-7 cells.
Bhatia A; Bhushan S; Singh B; Katare OP
J Liposome Res; 2009; 19(3):169-72. PubMed ID: 18991067
[TBL] [Abstract][Full Text] [Related]
35. [Characterization of vinflunine tartrate liposomes in vitro and in vivo].
Zou WW; Wang DH; Sun CY; Han JB; Yin Q; Yang QM; Wang JY
Yao Xue Xue Bao; 2011 Dec; 46(12):1515-9. PubMed ID: 22375428
[TBL] [Abstract][Full Text] [Related]
36. Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels.
Mourtas S; Duraj S; Fotopoulou S; Antimisiaris SG
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):270-6. PubMed ID: 17928204
[TBL] [Abstract][Full Text] [Related]
37. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
38. Lipophilic arabinofuranosyl cytosine derivatives in liposomes.
Schwendener R; Schott H
Methods Enzymol; 2005; 391():58-70. PubMed ID: 15721374
[TBL] [Abstract][Full Text] [Related]
39. Lipid composition and grafted PEG affect in vivo activity of liposomal mitoxantrone.
Li C; Cui J; Wang C; Wang J; Li Y; Zhang L; Zhang L; Guo W; Wang Y
Int J Pharm; 2008 Oct; 362(1-2):60-6. PubMed ID: 18598745
[TBL] [Abstract][Full Text] [Related]
40. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
